1. Home
  2. IMRN vs HUSA Comparison

IMRN vs HUSA Comparison

Compare IMRN & HUSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • HUSA
  • Stock Information
  • Founded
  • IMRN 1994
  • HUSA N/A
  • Country
  • IMRN Australia
  • HUSA United States
  • Employees
  • IMRN N/A
  • HUSA N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • HUSA Oil & Gas Production
  • Sector
  • IMRN Health Care
  • HUSA Energy
  • Exchange
  • IMRN Nasdaq
  • HUSA Nasdaq
  • Market Cap
  • IMRN 15.0M
  • HUSA 15.6M
  • IPO Year
  • IMRN N/A
  • HUSA N/A
  • Fundamental
  • Price
  • IMRN $1.81
  • HUSA $1.43
  • Analyst Decision
  • IMRN Strong Buy
  • HUSA
  • Analyst Count
  • IMRN 1
  • HUSA 0
  • Target Price
  • IMRN $5.00
  • HUSA N/A
  • AVG Volume (30 Days)
  • IMRN 6.2K
  • HUSA 582.1K
  • Earning Date
  • IMRN 11-26-2024
  • HUSA 11-29-2024
  • Dividend Yield
  • IMRN N/A
  • HUSA N/A
  • EPS Growth
  • IMRN N/A
  • HUSA N/A
  • EPS
  • IMRN N/A
  • HUSA N/A
  • Revenue
  • IMRN $3,271,194.00
  • HUSA $640,348.00
  • Revenue This Year
  • IMRN N/A
  • HUSA N/A
  • Revenue Next Year
  • IMRN N/A
  • HUSA N/A
  • P/E Ratio
  • IMRN N/A
  • HUSA N/A
  • Revenue Growth
  • IMRN 171.67
  • HUSA N/A
  • 52 Week Low
  • IMRN $1.59
  • HUSA $0.96
  • 52 Week High
  • IMRN $5.96
  • HUSA $2.57
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 35.96
  • HUSA 53.94
  • Support Level
  • IMRN $1.73
  • HUSA $1.34
  • Resistance Level
  • IMRN $1.99
  • HUSA $1.60
  • Average True Range (ATR)
  • IMRN 0.12
  • HUSA 0.10
  • MACD
  • IMRN 0.02
  • HUSA 0.01
  • Stochastic Oscillator
  • IMRN 20.42
  • HUSA 51.43

About IMRN Immuron Limited

Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

About HUSA Houston American Energy Corporation

Houston American Energy Corp is an independent oil and gas company focused on the development, exploration, exploitation, acquisition, and production of natural gas and crude oil properties. Its properties, and operations, are in the U.S. Permian Basin, the U.S. Gulf Coast region, particularly Texas and Louisiana, and the South American country of Colombia. The company's exploration and development projects are focused on existing property interests, and future acquisition of additional property interests, in the Texas Permian Basin, the onshore Texas and Louisiana Gulf Coast region, and the South American country of Colombia. The Company majorly has operations in two geographical areas, the United States and Colombia.

Share on Social Networks: